Abstract
Proteasome and HDAC inhibitors interact strongly to promote cell death in multiple myeloma and other human cancer cells. This study challenges current assumptions about the mechanisms underlying these interactions.
Cite
CITATION STYLE
APA
McConkey, D. (2010, July 22). Proteasome and HDAC: Who’s zooming who? Blood. American Society of Hematology. https://doi.org/10.1182/blood-2010-04-278507
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free